Personalizing Your
Cancer Journey
Precision Diagnostics
Who We Are
Qualisure Diagnostics Inc. develops molecular tests that enhance cancer care by identifying features that help oncologists personalize treatment.
Understanding which cancers are indolent or aggressive, and which ones are more likely to respond to certain treatments can guide treatment strategy.
Through innovation and collaboration, we help clinicians decide on the right treatment to provide personalized cancer care to every patient.
Introducing Thyroid GuidePx®
Helping guide your papillary thyroid cancer treatment journey!
Latest News
Qualisure Diagnostics and Invitrocue Announce Strategic Collaboration to Advance RNA-Based Precision Oncology Across Singapore and ASEAN
PRESS RELEASE Calgary, Canada and Singapore — 2026-08-21 Qualisure Diagnostics Inc. and Invitrocue today announced a strategic collaboration to introduce Thyroid GuidePx®, Qualisure’s RNA-based diagnostic for papillary thyroid cancer, to
Avoiding a Second Surgery: How Thyroid GuidePx® Can Help Patients Skip the Completion Thyroidectomy
Introduction For many patients diagnosed with papillary thyroid cancer, the first surgery is not always the only one. A significant number of people who have a lobectomy, where only part
Molecular Risk Testing: A Smarter System for Thyroid Cancer Care
Bathe, O. F. Open Access Govt July 2026. Published on 2026-06-03 Abstract Molecular risk testing: A smarter system for thyroid cancer care. Oliver Bathe, Professor of Surgery and Oncology at
Thyroid GuidePx®: A Smarter Way to Understand Papillary Thyroid Cancer
Introduction Papillary thyroid cancer is the most common type of thyroid cancer, and its incidence is increasing by approximately 6% every year. For most patients, the prognosis is good. But
Gene Expression Panels: Listening to What Your Tumor Is Doing
Introduction When most people think about cancer testing, they think about looking for something specific. A mutation, a protein, a genetic change. The tests we explored in our previous articles
Predictive Biomarkers: Matching the Right Treatment to the Right Patient
Introduction In our previous article, we explored the different categories of biomarkers used in cancer care, from those that signal disease risk to those that help monitor a patient’s response